eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Novartis Pharmaceuticals UK Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 692 255
Fax: +44 (0)1276 698 449
Medical Information Direct Line: +44 (0)1276 698 370
Medical Information e-mail: medinfo.uk@novartis.com
Customer Care direct line: +44 (0)845 741 9442

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 04/05/2012
PIL Aclasta 5 mg solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 04/05/2012 and displayed until Current
Reasons for adding or updating:
  • Change to dosage and administration
Updated on 09/02/2012 and displayed until 04/05/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change of contra-indications
  • Change to MA holder contact details
Updated on 19/07/2011 and displayed until 09/02/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 26/05/2010 and displayed until 19/07/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to dosage and administration
Updated on 06/08/2009 and displayed until 26/05/2010
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Changes to therapeutic indications
Updated on 11/11/2008 and displayed until 06/08/2009
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 23/10/2007 and displayed until 11/11/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 06/07/2006 and displayed until 23/10/2007
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   zoledronic acid monohydrate